Coloplast A/s Class B · OMXCOP:COLO_B
Coloplast A/s Class B — Investor Day (2017)
10 slides from Coloplast A/s Class B's investor day presentation, 2017
Slide 1: Wound & Skin Care
Wound & Skin Care Coloplast Meet the Management London 2017 Nicolai Buhl, SVP Wound & Skin Care Thomas Vigsø, VP US Wound & Skin Care
Slide 2: A year ago we launched a new ambition for our business
A year ago we launched a new ambition for our business … Shape the Double Become a truly standard of care our business global player …as scaling the business will be the key driver of improved profitability Page 2
Slide 3: With 6 clear execution themes
… with 6 clear “execution themes” • Together with HCPs create a shared standard for wound treatment by expanding 1 Shape the standard the awareness and understanding of the Triangle of Wound Assessment framework Build a strong product • Build a focused AWC product portfolio building on our Biatain s
Slide 4: We continue to take market share in Europe but momentum impacted by negative market dynamics
We continue to take market share in Europe but momentum impacted by negative market dynamics - particularly in EM NA EU ASIA EM Source: Coloplast Page 4
Slide 5: Our track record in Europe gives us confidence in our global ambition
Our track record in Europe gives us confidence in our global ambition Europe We are outgrowing the market in all countries in Europe Revenue growth (MAT index vs. LY) except France Sep Sep Sep Sep Sep 11/12 12/13 13/14 14/15 15/16 Source: Coloplast Page 5
Slide 6: We are investing in and progressing with our new ambition
We are investing in and progressing with our new ambition… 1 Shape the standard Endorsements Publications Build a strong product 2 PIP portfolio 3 Accelerate in EU Ramp-up Strengthen position 4 in the US New structure New management New investment plan Secure leading position 5 in China Revised targ
Slide 7: Attractive US value pool in Wound and Skin Care of ~$1.6bn with strong growth
Attractive US value pool in Wound and Skin Care of ~$1.6bn with strong growth rates US WSC market 2016/17 estimated value in $m (13/14 FY - 16/17 YTD CAGR) Wound Care Market: Skin Care Market: ~$850m, growing at 10% and we have <2% market share ~$800m, growing at 6% and we have ~8% market share 300
Slide 8: We believe we can make a difference in the US
We believe we can make a difference in the US With a new organisation and skilled management team in … and we have reason to believe we will succeed place we will drive growth through three initiatives … Focus on Acute channel Already present with many key and win with IDNs IDNs through strong SC po
Slide 9: Conclusion and summary
Conclusion and summary Victor 1. We are investing and fully executing on our strategic themes Current financial performance impacted by Emerging Markets 2. as well as price reforms in Greece and France We remain confident in our Wound & Skin Care value creation 3. opportunity and our strategic direc
Slide 10: Our mission, values and vision
Our mission Making life easier for peoplé with intimate healthcare needs Our values Closeness... to better understand. - Passion... to make a difference Respect and responsibility... to 0 guide | US: Our vision Setting the global standard for listening and responding: Coloplast A/S - Ostomy Care / C